Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.
| Autor: | Chapple, C. R.1 c.r.chapple@shef.ac.uk, Rechberger, T.2, Al-Shukri, S.3, Meffan, P.4, Everaert, K.5, Huang, M.6, Ridder, A.7 |
|---|---|
| Zdroj: | BJU International. Feb2004, Vol. 93 Issue 3, p303-310. 8p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|